SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
masonzhang
Lv1
40 积分
2023-10-17 加入
最近求助
最近应助
互助留言
Clinical Outcomes and Prognostic Factors of Metastatic Gastric Carcinoma Patients Who Experience Gastrointestinal Perforation During Palliative Chemotherapy
7天前
已完结
Evaluation of lymph nodes with RECIST 1.1
1个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
1个月前
已完结
The present and future of bispecific antibodies for cancer therapy
1个月前
已完结
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function
2个月前
已完结
Surrogate end points for survival in patients with advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
2个月前
已完结
Surrogate and modified endpoints for immunotherapy in advanced hepatocellular carcinoma
2个月前
已完结
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
2个月前
已完结
Optimizing the FDA’s Project Optimus: opportunities and challenges
2个月前
已完结
Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma
2个月前
已完结
没有进行任何应助
信息错误【积分已退回】
6个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论